Surufatinib Combined With TAS-102 in Third-line and Later-line Therapy of Patients With Advanced Pancreatic Cancer
Clinical trial NCT05481463 · COMPLETED
Trial details
- NCT number
- NCT05481463
- Sponsor
- Sun Yat-sen University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-30
- Primary completion
- 2025-03-31
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.